Detalhe da pesquisa
1.
Loss of liver function in chronic liver disease: An identity crisis.
J Hepatol
; 78(2): 401-414, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36115636
2.
Identification and experimental validation of druggable epigenetic targets in hepatoblastoma.
J Hepatol
; 79(4): 989-1005, 2023 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37302584
3.
The splicing regulator SLU7 is required to preserve DNMT1 protein stability and DNA methylation.
Nucleic Acids Res
; 49(15): 8592-8609, 2021 09 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-34331453
4.
Next-generation sequencing of bile cell-free DNA for the early detection of patients with malignant biliary strictures.
Gut
; 71(6): 1141-1151, 2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-34285068
5.
Chromatin dynamics during liver regeneration.
Semin Cell Dev Biol
; 97: 38-46, 2020 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30940574
6.
HOXD8 hypermethylation as a fully sensitive and specific biomarker for biliary tract cancer detectable in tissue and bile samples.
Br J Cancer
; 126(12): 1783-1794, 2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35177798
7.
Splicing Factor SLU7 Prevents Oxidative Stress-Mediated Hepatocyte Nuclear Factor 4α Degradation, Preserving Hepatic Differentiation and Protecting From Liver Damage.
Hepatology
; 74(5): 2791-2807, 2021 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34170569
8.
Dual Targeting of G9a and DNA Methyltransferase-1 for the Treatment of Experimental Cholangiocarcinoma.
Hepatology
; 73(6): 2380-2396, 2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33222246
9.
SLU7: A New Hub of Gene Expression Regulation-From Epigenetics to Protein Stability in Health and Disease.
Int J Mol Sci
; 23(21)2022 Nov 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36362191
10.
Metabolic-associated fatty liver disease: From simple steatosis toward liver cirrhosis and potential complications. Proceedings of the Third Translational Hepatology Meeting, organized by the Spanish Association for the Study of the Liver (AEEH).
Gastroenterol Hepatol
; 45(9): 724-734, 2022 Nov.
Artigo
em Inglês, Espanhol
| MEDLINE | ID: mdl-35248669
11.
Epigenetic mechanisms and metabolic reprogramming in fibrogenesis: dual targeting of G9a and DNMT1 for the inhibition of liver fibrosis.
Gut
; 70(2): 388-400, 2021 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-32327527
12.
ADAMTSL5 is an epigenetically activated gene underlying tumorigenesis and drug resistance in hepatocellular carcinoma.
J Hepatol
; 74(4): 893-906, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33197513
13.
Splicing events in the control of genome integrity: role of SLU7 and truncated SRSF3 proteins.
Nucleic Acids Res
; 47(7): 3450-3466, 2019 04 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-30657957
14.
Epigenetic Mechanisms in Gastric Cancer: Potential New Therapeutic Opportunities.
Int J Mol Sci
; 21(15)2020 Jul 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-32752096
15.
More than shots in the dark: improving patient stratification to move closer to personalised therapies in intrahepatic cholangiocarcinoma.
Gut
; 73(3): 389-390, 2024 Feb 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-37890989
16.
Evaluating the landscape of gene cooperativity with receptor tyrosine kinases in liver tumorigenesis using transposon-mediated mutagenesis.
J Hepatol
; 70(3): 470-482, 2019 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-30529386
17.
Proceedings of the 5th Meeting of Translational Hepatology, organized by the Spanish Association for the Study of the Liver (AEEH).
Gastroenterol Hepatol
; 2024 May 08.
Artigo
em Inglês, Espanhol
| MEDLINE | ID: mdl-38723772
18.
TWEAK promotes migration and invasion in MEFs through a mechanism dependent on ERKs activation and Fibulin 3 down-regulation.
J Cell Physiol
; 233(2): 968-978, 2018 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-28383766
19.
A phosphokinome-based screen uncovers new drug synergies for cancer driven by liver-specific gain of nononcogenic receptor tyrosine kinases.
Hepatology
; 66(5): 1644-1661, 2017 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-28586114
20.
Hepatic progenitor cells, senescence and IL-6 as the main players in combined hepatocellular-cholangiocarcinoma development.
J Hepatol
; 77(6): 1479-1481, 2022 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-36150576